Adco Nebrafen 4 ml Inhalant solution
PDF Leaflet Revision Date: 01 July 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of reversible airways obstruction.
Dosage (summary)
One ampoule for symptom relief; 3-4 times daily for long-term treatment.
Onset of Action / Duration
Onset: Rapid, Duration: ~6 hours
Special Populations
- Elderly
- Children under 18
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Beta-blockers may reduce effect
- Concomitant use with other bronchodilators may potentiate effects
Contraindications
- Hypersensitivity to active substances
- Hypertrophic obstructive cardiomyopathy
- Tachyarrhythmia
Common side effects
- Tremor
- Dizziness
- Headache
- Hypokalaemia
Counselling Points
- Use only as directed
- Monitor for side effects
- Avoid mist entering eyes
Serious warnings
- Overdosage may cause cardiac effects
- Caution in severe asthma
- Risk of hypokalaemia
Important Disclaimer
The Adco Nebrafen 4 ml Inhalant solution professional information leaflet below is the property of Adcock Ingram Critical Care and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
